An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)
Condition(s):Juvenile Idiopathic ArthritisLast Updated:February 21, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Juvenile Idiopathic ArthritisLast Updated:February 21, 2024Completed
Condition(s):Rheumatoid ArthritisLast Updated:March 13, 2017Completed
Condition(s):MalariaLast Updated:January 11, 2024Active, not recruiting
Condition(s):Autoimmune DiseasesLast Updated:July 21, 2017Completed
Condition(s):Uterine FibroidsLast Updated:September 4, 2019Completed
Condition(s):Chronic Lymphocytic LeukemiaLast Updated:September 22, 2021Completed
Condition(s):COVID-19Last Updated:March 26, 2024Completed
Condition(s):NarcolepsyLast Updated:April 18, 2023Completed
Condition(s):Rheumatoid ArthritisLast Updated:November 2, 2016Terminated
Condition(s):Basic Life Saving Skills; Cardiopulmonary Resuscitation; Skill RetentionLast Updated:December 19, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.